Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes

Makiko Nakamura1 Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan

Nobuo Sasai2 Sasai Clinic, Kanagawa, Japan

Ichiro Hisatome3 Division of Regenerative Medicine and Therapeutics, Institute of Regenerative Medicine and Biofunction, Graduate School of Medical Sciences, Tottori University, Tottori, Japan

Kimiyoshi Ichida1 Department of Pathophysiology, Tokyo University of Pharmacy and Life Sciences, Tokyo, JapanCorrespondence[email protected]

Pages 79-86 | Published online: 03 May 2014

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

MesserliFHFrohlichEDDreslinskiGRSuarezDHAristimunoGGSerum uric acid in essential hypertension: an indicator of renal vascular involvementAnn Intern Med1980938178217447188
PubMed Web of Science ®Google Scholar
LinKCLinHYChouPThe interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective studyJ Rheumatol2000271501150510852278
PubMed Web of Science ®Google Scholar
SavareseSFerriCTrimarcoBChanges in serum uric acid levels and cardiovascular events: a meta-analysisNut Metabol Cardiovas Dis201323707714
PubMed Web of Science ®Google Scholar
SedaghatSHoornEJvan RooijFJSerum uric acid and chronic kidney disease: The role of hypertensionPLOS One20138e7682724265674
PubMed Web of Science ®Google Scholar
ItoHAbeMMifuneMHyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitusPLOS One20116e2781722125626
PubMed Web of Science ®Google Scholar
NakamuraMAnzaiNJutabhaPSatoHSakuraiHIchidaKConcentration-dependent inhibitory effect of irbesartan on renal uric acid transportersJ Pharmacol Sci201011411511820736511
PubMed Web of Science ®Google Scholar
EnomotoAKimuraHChairoungduaAMolecular identification of a renal urate-anion exchanger that regulates blood urate levelsNature200241744745212024214
PubMed Web of Science ®Google Scholar
AnzaiNIchidaKJutabhaPPlasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humansJ Biol Chem2008283268342683818701466
PubMed Web of Science ®Google Scholar
IchidaKHosoyamadaMHisatomeIClinical and molecular analysis of patients with renal hypouricemia in Japan: influence of URAT1 gene on urinary urate excretionJ Am Soc Nephrol20041516417314694169
PubMed Web of Science ®Google Scholar
MatsuoHChibaTNagamoriSMutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemiaAm J Hum Genet20088374475119026395
PubMed Web of Science ®Google Scholar
DinourDGrayNKCampbellSHomozygous SLC2A9 mutations cause severe renal hypouricemiaJ Am Soc Nephrol201021647219926891
PubMed Web of Science ®Google Scholar
FauvelJPVelonSBerraNEffects of losartan on renal function in patients with essential hypertensionJ Cardiovasc Pharmacol1996282592638856482
PubMed Web of Science ®Google Scholar
ChoiHKSorianoLCZhangYRodríguezLAAntihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control studyBMJ2012344d819022240117
PubMed Web of Science ®Google Scholar
HamadaTIchidaKHosoyamadaMUricosuric action of losartan via the inhibition of urate transporter 1 (URAT1) in hypertensive patientsAm J Hypertens2008211157116218670416
PubMed Web of Science ®Google Scholar
NishidaYTakahashiYSusaNKanouNNakayamaTAsaiSComparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational studyCardiovasc Diabetol20131215924180232
PubMed Web of Science ®Google Scholar
DangAZhangYLiuGChenGSongWWangBEffects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese populationJ Hum Hypertens200620455016281062
PubMed Web of Science ®Google Scholar
CoronelFCigarránSGarcía-MenaMHerreroJACalvoNPérez-FloresIIrbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEINefrologia2008285660 Spanish18336132
PubMed Web of Science ®Google Scholar
WadaTHanedaMFuruichiKClinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetesClin Exp Nephrol Epub10172013
Web of Science ®Google Scholar
Curran-EverettDMultiple comparisons: philosophies and illustrationsAm J Physiol Regul Integr Comp Physiol2000279R1R810896857
PubMed Web of Science ®Google Scholar
KitamuraNTakahashiYYamadateSAsaiSAngiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical recordsCardiovasc Diabetol200762617903269
PubMed Web of Science ®Google Scholar
NishidaYTakahashiYNakayamaTAsaiSComparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetesCardiovasc Diabetol2012115322594344
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date